Scientists probe aging cells in fibroids for clues to new treatments
NCT ID NCT06135870
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study at Johns Hopkins University is looking at how aging cells (senescent cells) contribute to uterine fibroids, which are non-cancerous growths in the uterus. Researchers will analyze tissue samples from 150 women with fibroids to map these cells and their signals. The goal is to better understand the disease, not to test a new treatment.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this research could point toward new ways to treat or prevent uterine fibroids by targeting aging cells.
- What could go wrong
- This is an early observational study, not a treatment trial. It may not lead directly to therapies, and findings may not apply to all patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for FIBROID are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Johns Hopkins Hospital
RECRUITINGBaltimore, Maryland, 21287, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a single injection curb blood loss in fibroid surgery?
- Can watching videos before surgery calm nerves?
- A drug that may curb bleeding during fibroid surgery faces its first big test
- Could a common cholesterol drug shrink uterine fibroids?
- Single incision vs. multiple: which hysterectomy technique gets you home faster?
- Vitamin cocktail may shrink fibroids, reduce surgery need